These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35282420)

  • 81. Smear positive pulmonary tuberculosis among suspected patients attending metehara sugar factory hospital; eastern Ethiopia.
    Yohanes A; Abera S; Ali S
    Afr Health Sci; 2012 Sep; 12(3):325-30. PubMed ID: 23382747
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
    Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
    Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh.
    Biswas S; Uddin MKM; Paul KK; Ather MF; Ahmed S; Nasrin R; Kabir S; Heysell SK; Banu S
    Int J Infect Dis; 2022 Jan; 114():244-251. PubMed ID: 34774779
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India.
    Raizada N; Sachdeva KS; Sreenivas A; Kulsange S; Gupta RS; Thakur R; Dewan P; Boehme C; Paramsivan CN
    PLoS One; 2015; 10(2):e0116721. PubMed ID: 25658091
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Case finding of tuberculosis among mining communities in Ghana.
    Ohene SA; Bonsu F; Adusi-Poku Y; Dzata F; Bakker M
    PLoS One; 2021; 16(3):e0248718. PubMed ID: 33735298
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prevalence of pulmonary tuberculosis and associated risk factors in Eastern Ethiopian prisons.
    Abebe DS; Bjune G; Ameni G; Biffa D; Abebe F
    Int J Tuberc Lung Dis; 2011 May; 15(5):668-73. PubMed ID: 21756520
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
    Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H;
    PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children.
    Mulenga H; Tameris MD; Luabeya KK; Geldenhuys H; Scriba TJ; Hussey GD; Mahomed H; Landry BS; Hanekom WA; McShane H; Hatherill M
    Pediatr Infect Dis J; 2015 Nov; 34(11):1157-62. PubMed ID: 26226446
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prevalence and risk factors associated with tuberculosis disease in Suratthani Central Prison, Thailand.
    Morasert T; Worapas W; Kaewmahit R; Uphala W
    Int J Tuberc Lung Dis; 2018 Oct; 22(10):1203-1209. PubMed ID: 30236189
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Burden of tuberculosis and challenges related to screening and diagnosis in Ethiopia.
    Mohammed H; Oljira L; Roba KT; Ngadaya E; Ajeme T; Haile T; Kidane A; Manyazewal T; Fekadu A; Yimer G
    J Clin Tuberc Other Mycobact Dis; 2020 May; 19():100158. PubMed ID: 32258437
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Population Based National Tuberculosis Prevalence Survey among Adults (>15 Years) in Pakistan, 2010-2011.
    Qadeer E; Fatima R; Yaqoob A; Tahseen S; Ul Haq M; Ghafoor A; Asif M; Straetemans M; Tiemersma EW
    PLoS One; 2016; 11(2):e0148293. PubMed ID: 26863617
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study.
    Mulu W; Abera B; Yimer M; Hailu T; Ayele H; Abate D
    BMC Res Notes; 2017 Jan; 10(1):8. PubMed ID: 28057041
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The utility of Xpert MTB/RIF performed on bronchial washings obtained in patients with suspected pulmonary tuberculosis in a high prevalence setting.
    Barnard DA; Irusen EM; Bruwer JW; Plekker D; Whitelaw AC; Deetlefs JD; Koegelenberg CF
    BMC Pulm Med; 2015 Sep; 15():103. PubMed ID: 26377395
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Phenotypic and genotypic drug susceptibility patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Central and Southern Ethiopia.
    Tilahun M; Wegayehu T; Wondale B; Gebresilase TT; Gebreyohannes T; Tekola A; Alemu M; Neway S; Adnew B; Nassir MF; Kassahun Y; Aseffa A; Bobosha K
    PLoS One; 2023; 18(9):e0285063. PubMed ID: 37682820
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
    Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
    PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
    [TBL] [Abstract][Full Text] [Related]  

  • 97. How many of persistent coughers have pulmonary tuberculosis? Population-based cohort study in Ethiopia.
    Banti AB; Datiko DG; Hinderaker SG; Heldal E; Dangisso MH; Mitiku GA; White RA; Winje BA
    BMJ Open; 2022 May; 12(5):e058466. PubMed ID: 35613773
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Xpert MTB/RIF assay did not improve diagnosis of pulmonary tuberculosis among child contacts in Rwanda.
    Birungi FM; van Wyk B; Uwimana J; Ntaganira J; Graham SM
    Pan Afr Med J; 2018; 30():39. PubMed ID: 30167066
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Prevalence of tuberculosis in Rwanda: Results of the first nationwide survey in 2012 yielded important lessons for TB control.
    Migambi P; Gasana M; Uwizeye CB; Kamanzi E; Ndahindwa V; Kalisvaart N; Klinkenberg E
    PLoS One; 2020; 15(4):e0231372. PubMed ID: 32324750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.